These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12523450)

  • 1. Determinants of loneliness of young adult drug users.
    Rokach A
    J Psychol; 2002 Nov; 136(6):613-30. PubMed ID: 12523450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The causes of loneliness in homeless youth.
    Rokach A
    J Psychol; 2005 Sep; 139(5):469-80. PubMed ID: 16285216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-perception of the antecedents of loneliness among new mothers and pregnant women.
    Rokach A
    Psychol Rep; 2007 Feb; 100(1):231-43. PubMed ID: 17451030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loneliness and intimate partner violence:antecedents of alienation of abused women.
    Rokach A
    Soc Work Health Care; 2007; 45(1):19-31. PubMed ID: 17804345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations of perceived causes and the experience of loneliness.
    Rokach A
    Psychol Rep; 1997 Jun; 80(3 Pt 2):1067-74. PubMed ID: 9246875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
    Davis AK; Rosenberg H
    J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loneliness and the life cycle.
    Rokach A
    Psychol Rep; 2000 Apr; 86(2):629-42. PubMed ID: 10840922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
    Butler GK; Montgomery AM
    Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information processing speed in ecstasy (MDMA) users.
    Wareing M; Fisk JE; Montgomery C; Murphy PN; Chandler MD
    Hum Psychopharmacol; 2007 Mar; 22(2):81-8. PubMed ID: 17295197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychological aspects of MDMA (ecstasy) users].
    Varescon I
    Ann Med Interne (Paris); 2003 Nov; 154 Spec No 2():S81-5. PubMed ID: 14760230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.
    Halpern JH; Pope HG; Sherwood AR; Barry S; Hudson JI; Yurgelun-Todd D
    Drug Alcohol Depend; 2004 Aug; 75(2):135-47. PubMed ID: 15276218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Party people: personality and MDMA use of house party visitors.
    ter Bogt TF; Engels RC; Dubas JS
    Addict Behav; 2006 Jul; 31(7):1240-4. PubMed ID: 16143453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.